{"podcast":{"title":"The Vox Markets Podcast","slug":"the-vox-markets-podcast-3914537","podcast_index_feed_id":3914537,"rss_url":"https://audioboom.com/channels/5051662.rss","website_url":"https://audioboom.com/channels/5051662","image_url":"https://audioboom.com/i/40555564.png","author":"jruss88","episode_count":500,"summary":"Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.","last_synced_at":"2026-07-24T02:20:32.176878+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537"},"episode":{"title":"2382:  2026 Could Be a Defining Year for POLB 001 and Oral GLP-1","slug":"2382-2026-could-be-a-defining-year-for-polb-001-and-oral-glp-1","published_at":"2026-04-28T06:43:23+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2382-2026-could-be-a-defining-year-for-polb-001-and-oral-glp-1","show_page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537","url":"https://audioboom.com/posts/8896364","audio_url":"https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8896364.mp3?modified=1777358652&sid=5051662&source=rss","summary":"Poolbeg Pharma CEO Jeremy Skillington discusses progress across POLB 001, including regulatory clearance, IP protection, US payer research and the path towards interim clinical data in cancer immunotherapy-induced CRS. He also updates investors on the company’s cash runway, partnering strategy and the potential commercial opportunity in oral GLP-1 therapies.","meta_description":"Poolbeg Pharma CEO Jeremy Skillington discusses progress across POLB 001, including regulatory clearance, IP protection, US payer research and the path to…","key_points":[],"chapters":[],"topics":[],"duration_seconds":777,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2382-2026-could-be-a-defining-year-for-polb-001-and-oral-glp-1/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2382-2026-could-be-a-defining-year-for-polb-001-and-oral-glp-1.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}